China’s Wuhan Kindstar Gets $11M Infusion
China’s Wuhan Kindstar Diagnostics Co. has raised $11 million in Series B financing led by WI Harper Group, Baird Capital Partners Asia, Morningside Ventures and Mayo Clinic. Formed in 2003, Wuhan Kindstar provides laboratory testing services to over 2,000 Chinese hospitals. The company previously raised an undisclosed amount in Series A financing in 2008 from Morningside Ventures.
28 June 2011•4 mins read
